Supplementary Table S3 from Efficacy and Safety of Nivolumab Monotherapy in Patients with High PD-1–Positive CD8/Treg Ratio in Advanced NSCLC and Gastric Cancer: A Phase II, Multicenter Study Article Swipe

View

Kohei Shitara , Motohiro Tamiya , Kyoichi Okishio , Hisashi Hosaka , Katsunori Shinozaki , Nobuhiko Seki , Hiroki Hara , Yukiya Narita , Takeshi Shiraishi , Yosuke Tamura , Akihito Tsuji , Kunihiro Tsuji , Naohiro Watanabe , Hiroshi Tanaka , Toshifumi Yamaguchi , Kensei Yamaguchi , Hiroki Izumi , Yasunori Ushida , Hideaki Suna ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.1158/2767-9764.30344811

Post-progression anti-cancer therapy of the nivolumab monotherapy

Related Topics

Escape From L.A.

From The River To The Sea

The Rise And Fall Of Ziggy Stardust And The Spiders From Mars

Kiss From A Rose

Girl From The North Country (Musical)

Jenny From The Block

From Scratch (Tv Series)

The Last Letter From Your Lover

List Of United States Senators From Florida

Contingency Table

The Boy From Oz

Douglas Macarthur's Escape From The Philippines

Concepts

No concepts available.

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1158/2767-9764.30344811
OA Status: gold
OpenAlex ID: https://openalex.org/W4415104454

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4415104454

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/2767-9764.30344811

Digital Object Identifier
Title: Supplementary Table S3 from Efficacy and Safety of Nivolumab Monotherapy in Patients with High PD-1–Positive CD8/Treg Ratio in Advanced NSCLC and Gastric Cancer: A Phase II, Multicenter Study

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2025

Year of publication
Publication date: 2025-10-13

Full publication date if available
Authors: Kohei Shitara, Motohiro Tamiya, Kyoichi Okishio, Hisashi Hosaka, Katsunori Shinozaki, Nobuhiko Seki, Hiroki Hara, Yukiya Narita, Takeshi Shiraishi, Yosuke Tamura, Akihito Tsuji, Kunihiro Tsuji, Naohiro Watanabe, Hiroshi Tanaka, Toshifumi Yamaguchi, Kensei Yamaguchi, Hiroki Izumi, Yasunori Ushida, Hideaki Suna

List of authors in order
Landing page: https://doi.org/10.1158/2767-9764.30344811

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/2767-9764.30344811

Direct OA link when available
Cited by: 0

Total citation count in OpenAlex

Full payload

id	https://openalex.org/W4415104454
doi	https://doi.org/10.1158/2767-9764.30344811
ids.doi	https://doi.org/10.1158/2767-9764.30344811
ids.openalex	https://openalex.org/W4415104454
fwci	0.0
type	article
title	Supplementary Table S3 from Efficacy and Safety of Nivolumab Monotherapy in Patients with High PD-1–Positive CD8/Treg Ratio in Advanced NSCLC and Gastric Cancer: A Phase II, Multicenter Study
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10158
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9991000294685364
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2730
topics[0].subfield.display_name	Oncology
topics[0].display_name	Cancer Immunotherapy and Biomarkers
topics[1].id	https://openalex.org/T10696
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9954000115394592
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2740
topics[1].subfield.display_name	Pulmonary and Respiratory Medicine
topics[1].display_name	Gastric Cancer Management and Outcomes
topics[2].id	https://openalex.org/T11485
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9868000149726868
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2715
topics[2].subfield.display_name	Gastroenterology
topics[2].display_name	Gastrointestinal Tumor Research and Treatment
is_xpac	False
apc_list
apc_paid
language	en
locations[0].id	doi:10.1158/2767-9764.30344811
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/2767-9764.30344811
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5015799240
authorships[0].author.orcid	https://orcid.org/0000-0001-5196-3630
authorships[0].author.display_name	Kohei Shitara
authorships[0].author_position	first
authorships[0].raw_author_name	Kohei Shitara
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5036738616
authorships[1].author.orcid	https://orcid.org/0000-0001-6529-3092
authorships[1].author.display_name	Motohiro Tamiya
authorships[1].author_position	middle
authorships[1].raw_author_name	Motohiro Tamiya
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5001631780
authorships[2].author.orcid	https://orcid.org/0000-0002-6348-1302
authorships[2].author.display_name	Kyoichi Okishio
authorships[2].author_position	middle
authorships[2].raw_author_name	Kyoichi Okishio
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5020684025
authorships[3].author.orcid
authorships[3].author.display_name	Hisashi Hosaka
authorships[3].author_position	middle
authorships[3].raw_author_name	Hisashi Hosaka
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5101589150
authorships[4].author.orcid	https://orcid.org/0000-0003-0596-3423
authorships[4].author.display_name	Katsunori Shinozaki
authorships[4].author_position	middle
authorships[4].raw_author_name	Katsunori Shinozaki
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5062523486
authorships[5].author.orcid	https://orcid.org/0000-0002-6562-1137
authorships[5].author.display_name	Nobuhiko Seki
authorships[5].author_position	middle
authorships[5].raw_author_name	Nobuhiko Seki
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5050468802
authorships[6].author.orcid	https://orcid.org/0000-0003-3881-9815
authorships[6].author.display_name	Hiroki Hara
authorships[6].author_position	middle
authorships[6].raw_author_name	Hiroki Hara
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5032044936
authorships[7].author.orcid	https://orcid.org/0000-0002-8018-0077
authorships[7].author.display_name	Yukiya Narita
authorships[7].author_position	middle
authorships[7].raw_author_name	Yukiya Narita
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5113762402
authorships[8].author.orcid	https://orcid.org/0000-0001-9558-3576
authorships[8].author.display_name	Takeshi Shiraishi
authorships[8].author_position	middle
authorships[8].raw_author_name	Takeshi Shiraishi
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5110518386
authorships[9].author.orcid	https://orcid.org/0009-0000-0513-2860
authorships[9].author.display_name	Yosuke Tamura
authorships[9].author_position	middle
authorships[9].raw_author_name	Yosuke Tamura
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5062868734
authorships[10].author.orcid	https://orcid.org/0000-0003-4034-1945
authorships[10].author.display_name	Akihito Tsuji
authorships[10].author_position	middle
authorships[10].raw_author_name	Akihito Tsuji
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5022551435
authorships[11].author.orcid	https://orcid.org/0000-0001-7463-7272
authorships[11].author.display_name	Kunihiro Tsuji
authorships[11].author_position	middle
authorships[11].raw_author_name	Kunihiro Tsuji
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5112470169
authorships[12].author.orcid
authorships[12].author.display_name	Naohiro Watanabe
authorships[12].author_position	middle
authorships[12].raw_author_name	Naohiro Watanabe
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5101700468
authorships[13].author.orcid	https://orcid.org/0000-0002-8003-7326
authorships[13].author.display_name	Hiroshi Tanaka
authorships[13].author_position	middle
authorships[13].raw_author_name	Hiroshi Tanaka
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5077816256
authorships[14].author.orcid	https://orcid.org/0000-0003-1399-1918
authorships[14].author.display_name	Toshifumi Yamaguchi
authorships[14].author_position	middle
authorships[14].raw_author_name	Toshifumi Yamaguchi
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5091701897
authorships[15].author.orcid	https://orcid.org/0000-0001-6887-5709
authorships[15].author.display_name	Kensei Yamaguchi
authorships[15].author_position	middle
authorships[15].raw_author_name	Kensei Yamaguchi
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5005405732
authorships[16].author.orcid	https://orcid.org/0000-0002-9566-4859
authorships[16].author.display_name	Hiroki Izumi
authorships[16].author_position	middle
authorships[16].raw_author_name	Hiroki Izumi
authorships[16].is_corresponding	False
authorships[17].author.id	https://openalex.org/A5074652625
authorships[17].author.orcid
authorships[17].author.display_name	Yasunori Ushida
authorships[17].author_position	middle
authorships[17].raw_author_name	Yasunori Ushida
authorships[17].is_corresponding	False
authorships[18].author.id	https://openalex.org/A5084823254
authorships[18].author.orcid	https://orcid.org/0000-0001-9202-316X
authorships[18].author.display_name	Hideaki Suna
authorships[18].author_position	last
authorships[18].raw_author_name	Hideaki Suna
authorships[18].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/2767-9764.30344811
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-13T00:00:00
display_name	Supplementary Table S3 from Efficacy and Safety of Nivolumab Monotherapy in Patients with High PD-1–Positive CD8/Treg Ratio in Advanced NSCLC and Gastric Cancer: A Phase II, Multicenter Study
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10158
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9991000294685364
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2730
primary_topic.subfield.display_name	Oncology
primary_topic.display_name	Cancer Immunotherapy and Biomarkers
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1158/2767-9764.30344811
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/2767-9764.30344811
primary_location.id	doi:10.1158/2767-9764.30344811
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/2767-9764.30344811
publication_date	2025-10-13
publication_year	2025
referenced_works_count	0
abstract_inverted_index.of	3
abstract_inverted_index.the	4
abstract_inverted_index.therapy	2
abstract_inverted_index.nivolumab	5
abstract_inverted_index.anti-cancer	1
abstract_inverted_index.monotherapy</p>	6
abstract_inverted_index.<p>Post-progression	0
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	19
citation_normalized_percentile.value	0.63198557
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False